Data Access. |
Global health data for insights that drive confident, strategic decision making.
IHME Client Services provides data and analytics to support the use of IHME's health database. We're your partner in facilitating
licensing agreements that allow commercial users to apply IHME data to business needs.
licensing agreements that allow commercial users to apply IHME data to business needs.
Our data is comprehensive
|
The Global Burden of Disease (GBD) study measures health outcomes through measures of epidemiology, health burden, risk factors, and outcomes to compare across groups equitably. We house 39+ billion rows of structured data on diseases, risks, and outcomes. View our full availability below.
|
Highlights
Condition-specific burden |
Estimates of 365+ diseases and injuries and 2,500+ disease subtypes or sequelae Incidence, prevalence, and deaths Summary measures of condition-specific burden such as: Disability weights Years lived with disability (YLDs) Years of life lost (YLLs) Disability adjusted life-years (DALYs) |
Risk factor attribution |
Exposure to 97+ risk factors and categories of risks (behavioral, metabolic, environmental, occupational drivers of disease) Includes share of deaths and DALYs attributed to each risk |
Forecasts |
Condition-specific burden forecasts through 2050 All-cause mortality and longevity projections through 2100 |
Population structure |
Underlying population structure |
Subnational locations |
Brazil, China, Ethiopia, India, Indonesia, Iran, Italy, Japan, Kenya, Mexico, New Zealand, Nigeria, Norway, Pakistan, Philippines, Poland, Russia, South Africa, Sweden, United Kingdom, USA. |
Brain Health Initiative Measuring the effects of neurological, cerebrovascular, and mental health disorders globally. Inclusivity Initiative Addressing the need for health strategies that are more inclusive and responsive to the needs of diverse populations. Resilience Initiative Developing new data to better anticipate and inform response to threats, measuring health and wellness of the planet and people. Immunity Initiative Actionable evidence to drive change in addressing the burden of infectious diseases including vaccine preventable diseases and AMR. Social Impact Initiative Scalable measurement strategies to target health investments and quantify health impact. |
|
Therapeutic areas |
Cardiology, Dermatology, Diabetes, Gastroenterology, Hematology, Immunology, Infectious Disease & Vaccines, Metabolism & Endocrinology, Neurology, Oncology, Ophthalmology, Orthopedics, Pediatrics, Mental Health Disorders, Respiratory, Rheumatology, Substance Abuse, Urology, Women’s Health |
How we work with you
Customized PricingPricing is based on the number of locations and conditions with options to access IHME’s past trends and forecasts for every country in the world.
|
Dedicated Client Portal Licenses include access via a dedicated client portal, including data download and visualization tools. Licenses include access to online training materials, and dedicated consultation time based on the package selected. View a demo of the IHME client portal below:
|
See our recent publications for how these insights can be applied to your work.